Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new diabetes drug to see if it is safe and works better than the current best treatment.
- Type 2 Diabetes
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is GLY-200 officially certified by the FDA?
"Using a scale of 1 to 3, our team at Power has appraised the safety profile of GLY-200 as '2'. This is because this Phase 2 trial features some evidence regarding its security yet lacks data on efficacy."
What criteria must be met to participate in this clinical experiment?
"This trial is actively searching for 48 individuals aged between 30 and 70 who have been diagnosed with type 2 diabetes mellitus. Of note, applicants must possess a Body Mass Index that falls between 18 to 40 at screening as well as an HbA1c level ranging from 6 to 8.5%."
Does the enrollment criteria for this experiment include individuals above 80 years of age?
"This study requires prospective participants to be between 30 and 70 years old. Those under the age of 18 have access to 52 clinical trials, while those above 65 can choose from 736 available options."
Are there opportunities for people to participate in this experiment?
"Affirmative, the information published on clinicaltrials.gov reveals that this trial is currently in search of participants. Initially posted 8th March 2022 and last amended 28th October 2022, 48 patients are required to be recruited from a single location."
What is the cap on the number of participants involved in this clinical trial?
"Affirmative. The clinicaltrials.gov website asserts that this medical research, which was originally announced on August 3rd 2022, is currently looking for participants. A total of 48 individuals need to be enrolled from 1 separate healthcare facility."
Share this study with friends
Copy Link
Messenger